The event brought together investors, industry leaders, mentors, and community partners in a sold-out room that demonstrated just how much momentum is building around inclusive biotech entrepreneurship.
Five of HiveBio’s portfolio companies — Ajaya Bio, Trevarx Biomedical, Cerespectus™, BioLattice Ophthalmics, and Vasowatch Inc. — have earned a spot to pitch on stage at the 2025 Mid-Atlantic Capital Conference.